CMS Announces Second Wave of Medicare Drug Price Negotiations Under Inflation Reduction Act, Targeting 15 High-Expenditure Therapeutics
CMS has selected 15 high-expenditure therapeutics for the second wave of Medicare drug price negotiations under the Infl...
Read More →
